Global SPECT and PET Radiopharmaceuticals Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global SPECT and PET Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the SPECT and PET Radiopharmaceuticals industry chain, the market status of Hospitals (Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals, Positron Emission Tomography (PET) Radiopharmaceuticals), Clinics (Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals, Positron Emission Tomography (PET) Radiopharmaceuticals), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of SPECT and PET Radiopharmaceuticals.

Regionally, the report analyzes the SPECT and PET Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global SPECT and PET Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the SPECT and PET Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the SPECT and PET Radiopharmaceuticals industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals, Positron Emission Tomography (PET) Radiopharmaceuticals).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the SPECT and PET Radiopharmaceuticals market.

Regional Analysis: The report involves examining the SPECT and PET Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the SPECT and PET Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to SPECT and PET Radiopharmaceuticals:
Company Analysis: Report covers individual SPECT and PET Radiopharmaceuticals players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards SPECT and PET Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to SPECT and PET Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in SPECT and PET Radiopharmaceuticals areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the SPECT and PET Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
SPECT and PET Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
    Positron Emission Tomography (PET) Radiopharmaceuticals

Market segment by Application
    Hospitals
    Clinics
    Others

Market segment by players, this report covers
    GE Healthcare
    Cardinal Health
    Curium Pharma
    China Isotope & Radiation
    Jubilant Life Sciences
    Bracco
    Yantai Dongcheng Pharmaceutical
    Lantheus Medical Imaging, Inc.
    Eczacıbaşı Monrol Nuclear Products
    Novartis International AG
    Siemens

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe SPECT and PET Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of SPECT and PET Radiopharmaceuticals, with revenue, gross margin and global market share of SPECT and PET Radiopharmaceuticals from 2018 to 2023.
Chapter 3, the SPECT and PET Radiopharmaceuticals competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and SPECT and PET Radiopharmaceuticals market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of SPECT and PET Radiopharmaceuticals.
Chapter 13, to describe SPECT and PET Radiopharmaceuticals research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of SPECT and PET Radiopharmaceuticals
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of SPECT and PET Radiopharmaceuticals by Type
        1.3.1 Overview: Global SPECT and PET Radiopharmaceuticals Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type in 2022
        1.3.3 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
        1.3.4 Positron Emission Tomography (PET) Radiopharmaceuticals
    1.4 Global SPECT and PET Radiopharmaceuticals Market by Application
        1.4.1 Overview: Global SPECT and PET Radiopharmaceuticals Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Others
    1.5 Global SPECT and PET Radiopharmaceuticals Market Size & Forecast
    1.6 Global SPECT and PET Radiopharmaceuticals Market Size and Forecast by Region
        1.6.1 Global SPECT and PET Radiopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global SPECT and PET Radiopharmaceuticals Market Size by Region, (2018-2029)
        1.6.3 North America SPECT and PET Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.4 Europe SPECT and PET Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.6 South America SPECT and PET Radiopharmaceuticals Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 GE Healthcare
        2.1.1 GE Healthcare Details
        2.1.2 GE Healthcare Major Business
        2.1.3 GE Healthcare SPECT and PET Radiopharmaceuticals Product and Solutions
        2.1.4 GE Healthcare SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GE Healthcare Recent Developments and Future Plans
    2.2 Cardinal Health
        2.2.1 Cardinal Health Details
        2.2.2 Cardinal Health Major Business
        2.2.3 Cardinal Health SPECT and PET Radiopharmaceuticals Product and Solutions
        2.2.4 Cardinal Health SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Cardinal Health Recent Developments and Future Plans
    2.3 Curium Pharma
        2.3.1 Curium Pharma Details
        2.3.2 Curium Pharma Major Business
        2.3.3 Curium Pharma SPECT and PET Radiopharmaceuticals Product and Solutions
        2.3.4 Curium Pharma SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Curium Pharma Recent Developments and Future Plans
    2.4 China Isotope & Radiation
        2.4.1 China Isotope & Radiation Details
        2.4.2 China Isotope & Radiation Major Business
        2.4.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product and Solutions
        2.4.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 China Isotope & Radiation Recent Developments and Future Plans
    2.5 Jubilant Life Sciences
        2.5.1 Jubilant Life Sciences Details
        2.5.2 Jubilant Life Sciences Major Business
        2.5.3 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product and Solutions
        2.5.4 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Jubilant Life Sciences Recent Developments and Future Plans
    2.6 Bracco
        2.6.1 Bracco Details
        2.6.2 Bracco Major Business
        2.6.3 Bracco SPECT and PET Radiopharmaceuticals Product and Solutions
        2.6.4 Bracco SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bracco Recent Developments and Future Plans
    2.7 Yantai Dongcheng Pharmaceutical
        2.7.1 Yantai Dongcheng Pharmaceutical Details
        2.7.2 Yantai Dongcheng Pharmaceutical Major Business
        2.7.3 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product and Solutions
        2.7.4 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Yantai Dongcheng Pharmaceutical Recent Developments and Future Plans
    2.8 Lantheus Medical Imaging, Inc.
        2.8.1 Lantheus Medical Imaging, Inc. Details
        2.8.2 Lantheus Medical Imaging, Inc. Major Business
        2.8.3 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product and Solutions
        2.8.4 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Lantheus Medical Imaging, Inc. Recent Developments and Future Plans
    2.9 Eczacıbaşı Monrol Nuclear Products
        2.9.1 Eczacıbaşı Monrol Nuclear Products Details
        2.9.2 Eczacıbaşı Monrol Nuclear Products Major Business
        2.9.3 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product and Solutions
        2.9.4 Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Eczacıbaşı Monrol Nuclear Products Recent Developments and Future Plans
    2.10 Novartis International AG
        2.10.1 Novartis International AG Details
        2.10.2 Novartis International AG Major Business
        2.10.3 Novartis International AG SPECT and PET Radiopharmaceuticals Product and Solutions
        2.10.4 Novartis International AG SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Novartis International AG Recent Developments and Future Plans
    2.11 Siemens
        2.11.1 Siemens Details
        2.11.2 Siemens Major Business
        2.11.3 Siemens SPECT and PET Radiopharmaceuticals Product and Solutions
        2.11.4 Siemens SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Siemens Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global SPECT and PET Radiopharmaceuticals Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of SPECT and PET Radiopharmaceuticals by Company Revenue
        3.2.2 Top 3 SPECT and PET Radiopharmaceuticals Players Market Share in 2022
        3.2.3 Top 6 SPECT and PET Radiopharmaceuticals Players Market Share in 2022
    3.3 SPECT and PET Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.3.1 SPECT and PET Radiopharmaceuticals Market: Region Footprint
        3.3.2 SPECT and PET Radiopharmaceuticals Market: Company Product Type Footprint
        3.3.3 SPECT and PET Radiopharmaceuticals Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global SPECT and PET Radiopharmaceuticals Consumption Value and Market Share by Type (2018-2023)
    4.2 Global SPECT and PET Radiopharmaceuticals Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application (2018-2023)
    5.2 Global SPECT and PET Radiopharmaceuticals Market Forecast by Application (2024-2029)

6 North America
    6.1 North America SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2029)
    6.2 North America SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2029)
    6.3 North America SPECT and PET Radiopharmaceuticals Market Size by Country
        6.3.1 North America SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2029)
        6.3.2 United States SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        6.3.3 Canada SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        6.3.4 Mexico SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2029)
    7.2 Europe SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2029)
    7.3 Europe SPECT and PET Radiopharmaceuticals Market Size by Country
        7.3.1 Europe SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2029)
        7.3.2 Germany SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.3 France SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.5 Russia SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        7.3.6 Italy SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific SPECT and PET Radiopharmaceuticals Market Size by Region
        8.3.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Region (2018-2029)
        8.3.2 China SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.3 Japan SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.4 South Korea SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.5 India SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        8.3.7 Australia SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)

9 South America
    9.1 South America SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2029)
    9.2 South America SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2029)
    9.3 South America SPECT and PET Radiopharmaceuticals Market Size by Country
        9.3.1 South America SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2029)
        9.3.2 Brazil SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        9.3.3 Argentina SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Country
        10.3.1 Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2029)
        10.3.2 Turkey SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)
        10.3.4 UAE SPECT and PET Radiopharmaceuticals Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 SPECT and PET Radiopharmaceuticals Market Drivers
    11.2 SPECT and PET Radiopharmaceuticals Market Restraints
    11.3 SPECT and PET Radiopharmaceuticals Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 SPECT and PET Radiopharmaceuticals Industry Chain
    12.2 SPECT and PET Radiopharmaceuticals Upstream Analysis
    12.3 SPECT and PET Radiopharmaceuticals Midstream Analysis
    12.4 SPECT and PET Radiopharmaceuticals Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global SPECT and PET Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global SPECT and PET Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global SPECT and PET Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global SPECT and PET Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. GE Healthcare Company Information, Head Office, and Major Competitors
    Table 6. GE Healthcare Major Business
    Table 7. GE Healthcare SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 8. GE Healthcare SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. GE Healthcare Recent Developments and Future Plans
    Table 10. Cardinal Health Company Information, Head Office, and Major Competitors
    Table 11. Cardinal Health Major Business
    Table 12. Cardinal Health SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 13. Cardinal Health SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Cardinal Health Recent Developments and Future Plans
    Table 15. Curium Pharma Company Information, Head Office, and Major Competitors
    Table 16. Curium Pharma Major Business
    Table 17. Curium Pharma SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 18. Curium Pharma SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Curium Pharma Recent Developments and Future Plans
    Table 20. China Isotope & Radiation Company Information, Head Office, and Major Competitors
    Table 21. China Isotope & Radiation Major Business
    Table 22. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 23. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. China Isotope & Radiation Recent Developments and Future Plans
    Table 25. Jubilant Life Sciences Company Information, Head Office, and Major Competitors
    Table 26. Jubilant Life Sciences Major Business
    Table 27. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 28. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Jubilant Life Sciences Recent Developments and Future Plans
    Table 30. Bracco Company Information, Head Office, and Major Competitors
    Table 31. Bracco Major Business
    Table 32. Bracco SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 33. Bracco SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Bracco Recent Developments and Future Plans
    Table 35. Yantai Dongcheng Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 36. Yantai Dongcheng Pharmaceutical Major Business
    Table 37. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 38. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Yantai Dongcheng Pharmaceutical Recent Developments and Future Plans
    Table 40. Lantheus Medical Imaging, Inc. Company Information, Head Office, and Major Competitors
    Table 41. Lantheus Medical Imaging, Inc. Major Business
    Table 42. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 43. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Lantheus Medical Imaging, Inc. Recent Developments and Future Plans
    Table 45. Eczacıbaşı Monrol Nuclear Products Company Information, Head Office, and Major Competitors
    Table 46. Eczacıbaşı Monrol Nuclear Products Major Business
    Table 47. Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 48. Eczacıbaşı Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Eczacıbaşı Monrol Nuclear Products Recent Developments and Future Plans
    Table 50. Novartis International AG Company Information, Head Office, and Major Competitors
    Table 51. Novartis International AG Major Business
    Table 52. Novartis International AG SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 53. Novartis International AG SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Novartis International AG Recent Developments and Future Plans
    Table 55. Siemens Company Information, Head Office, and Major Competitors
    Table 56. Siemens Major Business
    Table 57. Siemens SPECT and PET Radiopharmaceuticals Product and Solutions
    Table 58. Siemens SPECT and PET Radiopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Siemens Recent Developments and Future Plans
    Table 60. Global SPECT and PET Radiopharmaceuticals Revenue (USD Million) by Players (2018-2023)
    Table 61. Global SPECT and PET Radiopharmaceuticals Revenue Share by Players (2018-2023)
    Table 62. Breakdown of SPECT and PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in SPECT and PET Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 64. Head Office of Key SPECT and PET Radiopharmaceuticals Players
    Table 65. SPECT and PET Radiopharmaceuticals Market: Company Product Type Footprint
    Table 66. SPECT and PET Radiopharmaceuticals Market: Company Product Application Footprint
    Table 67. SPECT and PET Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
    Table 68. SPECT and PET Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global SPECT and PET Radiopharmaceuticals Consumption Value (USD Million) by Type (2018-2023)
    Table 70. Global SPECT and PET Radiopharmaceuticals Consumption Value Share by Type (2018-2023)
    Table 71. Global SPECT and PET Radiopharmaceuticals Consumption Value Forecast by Type (2024-2029)
    Table 72. Global SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2023)
    Table 73. Global SPECT and PET Radiopharmaceuticals Consumption Value Forecast by Application (2024-2029)
    Table 74. North America SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 75. North America SPECT and PET Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 76. North America SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. North America SPECT and PET Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. North America SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 79. North America SPECT and PET Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 80. Europe SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Europe SPECT and PET Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Europe SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 83. Europe SPECT and PET Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 84. Europe SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe SPECT and PET Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 87. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 88. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 89. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 90. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 91. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 92. South America SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 93. South America SPECT and PET Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 94. South America SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 95. South America SPECT and PET Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 96. South America SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. South America SPECT and PET Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 99. Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 100. Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 101. Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 102. Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 103. Middle East & Africa SPECT and PET Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 104. SPECT and PET Radiopharmaceuticals Raw Material
    Table 105. Key Suppliers of SPECT and PET Radiopharmaceuticals Raw Materials
List of Figures
    Figure 1. SPECT and PET Radiopharmaceuticals Picture
    Figure 2. Global SPECT and PET Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type in 2022
    Figure 4. Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
    Figure 5. Positron Emission Tomography (PET) Radiopharmaceuticals
    Figure 6. Global SPECT and PET Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application in 2022
    Figure 8. Hospitals Picture
    Figure 9. Clinics Picture
    Figure 10. Others Picture
    Figure 11. Global SPECT and PET Radiopharmaceuticals Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global SPECT and PET Radiopharmaceuticals Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market SPECT and PET Radiopharmaceuticals Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Region in 2022
    Figure 16. North America SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global SPECT and PET Radiopharmaceuticals Revenue Share by Players in 2022
    Figure 22. SPECT and PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players SPECT and PET Radiopharmaceuticals Market Share in 2022
    Figure 24. Global Top 6 Players SPECT and PET Radiopharmaceuticals Market Share in 2022
    Figure 25. Global SPECT and PET Radiopharmaceuticals Consumption Value Share by Type (2018-2023)
    Figure 26. Global SPECT and PET Radiopharmaceuticals Market Share Forecast by Type (2024-2029)
    Figure 27. Global SPECT and PET Radiopharmaceuticals Consumption Value Share by Application (2018-2023)
    Figure 28. Global SPECT and PET Radiopharmaceuticals Market Share Forecast by Application (2024-2029)
    Figure 29. North America SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 39. France SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 46. China SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 49. India SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa SPECT and PET Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE SPECT and PET Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 63. SPECT and PET Radiopharmaceuticals Market Drivers
    Figure 64. SPECT and PET Radiopharmaceuticals Market Restraints
    Figure 65. SPECT and PET Radiopharmaceuticals Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of SPECT and PET Radiopharmaceuticals in 2022
    Figure 68. Manufacturing Process Analysis of SPECT and PET Radiopharmaceuticals
    Figure 69. SPECT and PET Radiopharmaceuticals Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

GE Healthcare
Cardinal Health
Curium Pharma
China Isotope & Radiation
Jubilant Life Sciences
Bracco
Yantai Dongcheng Pharmaceutical
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens